China Regenerative Medicine International Limited (8158.HK)
- Previous Close
0.280 - Open
0.285 - Bid 0.105 x --
- Ask 0.300 x --
- Day's Range
0.285 - 0.285 - 52 Week Range
0.270 - 1.190 - Volume
40,000 - Avg. Volume
21,390 - Market Cap (intraday)
82.148M - Beta (5Y Monthly) 1.94
- PE Ratio (TTM)
-- - EPS (TTM)
-0.380 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 24, 2002
- 1y Target Est
--
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People's Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
www.crmi.hkRelated News
Performance Overview: 8158.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8158.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8158.HK
Valuation Measures
Market Cap
82.15M
Enterprise Value
129.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.18
Price/Book (mrq)
6.97
Enterprise Value/Revenue
1.86
Enterprise Value/EBITDA
-1.21
Financial Highlights
Profitability and Income Statement
Profit Margin
-154.99%
Return on Assets (ttm)
-7.07%
Return on Equity (ttm)
-186.15%
Revenue (ttm)
69.49M
Net Income Avi to Common (ttm)
-107.7M
Diluted EPS (ttm)
-0.380
Balance Sheet and Cash Flow
Total Cash (mrq)
3.33M
Total Debt/Equity (mrq)
425.60%
Levered Free Cash Flow (ttm)
--
Company Insights: 8158.HK
8158.HK does not have Company Insights